73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Toxicity data reveal no safety concerns with S/N1806 bladder cancer trial

Toxicity data reveal no safety concerns with S/N1806 bladder cancer trial

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainUpdated toxicity data from the ongoing SWOG/NRG 1806 clinical trial, which tests combining chemoradiation therapy with immunotherapy in

Toxicity data reveal no safety concerns with S/N1806 bladder cancer trial

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainUpdated toxicity data from the ongoing SWOG/NRG 1806 clinical trial, which tests combining chemoradiation therapy with immunotherapy in
Tail spin: Study reveals new way to reduce friendly fire in cell therapy

Tail spin: Study reveals new way to reduce friendly fire in cell therapy

by Bill Hathaway,Yale UniversityIn CAR-T therapy, T cells in blue find antigens (red) and kill cancer cells (purple). But often, antigens attach to other T cells leading other T cells to attack

Tail spin: Study reveals new way to reduce friendly fire in cell therapy

by Bill Hathaway,Yale UniversityIn CAR-T therapy, T cells in blue find antigens (red) and kill cancer cells (purple). But often, antigens attach to other T cells leading other T cells to attack
Scientists find dramatic rise in anal cancer in Midwest and Southeast

Scientists find dramatic rise in anal cancer in Midwest and Southeast

by Caroline Wallace,Medical University of South CarolinaCredit: Unsplash/CC0 Public DomainSouth Carolina is seeing one of the fastest rises in anal cancer incidence among women and anal cancer m

Scientists find dramatic rise in anal cancer in Midwest and Southeast

by Caroline Wallace,Medical University of South CarolinaCredit: Unsplash/CC0 Public DomainSouth Carolina is seeing one of the fastest rises in anal cancer incidence among women and anal cancer m
Single-cell 'atlas' reveals origin of an aggressive brain tumor

Single-cell 'atlas' reveals origin of an aggressive brain tumor

byCincinnati Children's Hospital Medical CenterChartshows that mice with reduced activity of either the SOX11 or HNRNOH1 genes had longer survival times when induced to develop medullo

Single-cell 'atlas' reveals origin of an aggressive brain tumor

byCincinnati Children's Hospital Medical CenterChartshows that mice with reduced activity of either the SOX11 or HNRNOH1 genes had longer survival times when induced to develop medullo
Cancer cells hijack enhancer DNA to grow faster, study finds

Cancer cells hijack enhancer DNA to grow faster, study finds

University of Toronto (U of T) researchers have found that cancer cells can enhance tumor growth by hijacking enhancer DNA normally used when tissues and organs are formed. The mechanism, called enhan

Cancer cells hijack enhancer DNA to grow faster, study finds

University of Toronto (U of T) researchers have found that cancer cells can enhance tumor growth by hijacking enhancer DNA normally used when tissues and organs are formed. The mechanism, called enhan
Intestinal microorganisms influence white blood cell levels, study finds

Intestinal microorganisms influence white blood cell levels, study finds

by Hokkaido UniversityUnder normal conditions (steady state) neutrophils regulate the gut microbiota. When the number of neutrophils drops (neutropenia), the composition of the gut microbiota cha

Intestinal microorganisms influence white blood cell levels, study finds

by Hokkaido UniversityUnder normal conditions (steady state) neutrophils regulate the gut microbiota. When the number of neutrophils drops (neutropenia), the composition of the gut microbiota cha
Algorithm offers new way to spot patients likely to respond to immunotherapy

Algorithm offers new way to spot patients likely to respond to immunotherapy

byInstitute of Cancer ResearchOverview of immune selection calculation using SOPRANO. a, Estimates can be performed at the cohort or at the single individual level. b, In each case, it is possib

Algorithm offers new way to spot patients likely to respond to immunotherapy

byInstitute of Cancer ResearchOverview of immune selection calculation using SOPRANO. a, Estimates can be performed at the cohort or at the single individual level. b, In each case, it is possib
Scientists identify potential drug target for BRCA-mutated tumours

Scientists identify potential drug target for BRCA-mutated tumours

byInstitute of Cancer ResearchCrystal structure of EXD2 exonuclease domain in spacefill format. Credit: Image generated fromPDBA new study has uncovered a previously unknown role for the e

Scientists identify potential drug target for BRCA-mutated tumours

byInstitute of Cancer ResearchCrystal structure of EXD2 exonuclease domain in spacefill format. Credit: Image generated fromPDBA new study has uncovered a previously unknown role for the e
BCMA-targeted immunotherapy can lead to durable responses in multiple myeloma

BCMA-targeted immunotherapy can lead to durable responses in multiple myeloma

byPerelman School of Medicine at the University of PennsylvaniaMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0An experim

BCMA-targeted immunotherapy can lead to durable responses in multiple myeloma

byPerelman School of Medicine at the University of PennsylvaniaMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0An experim
3-D mammography detected 34% more breast cancers in screening

3-D mammography detected 34% more breast cancers in screening

byLund UniversityUsing breast tomosynthesis (3D screening) in the image to the left (one of about 50 thin cross-sectional image slices of the breast), you can see an approximately 1 cm-large tum

3-D mammography detected 34% more breast cancers in screening

byLund UniversityUsing breast tomosynthesis (3D screening) in the image to the left (one of about 50 thin cross-sectional image slices of the breast), you can see an approximately 1 cm-large tum
Structural analysis reveals an unexpected mechanism for a cancer drug

Structural analysis reveals an unexpected mechanism for a cancer drug

by Tim Stephens,University of California - Santa CruzThe breast cancer drug palbociclib (grey) interacts with its target protein CDK4 (green) in this structural model. Binding of the activator p

Structural analysis reveals an unexpected mechanism for a cancer drug

by Tim Stephens,University of California - Santa CruzThe breast cancer drug palbociclib (grey) interacts with its target protein CDK4 (green) in this structural model. Binding of the activator p